Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Hong

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nanotechnology|August 12, 2011
Surface enhanced Raman scattering of silver sensitized cobalt nanoparticles in metal-dielectric nanocompositesJ Margueritat, J Gonzalo, C N Afonso, et al.
International Journal of Impotence Research|October 29, 2004
Post-marketing surveillance study of the safety and efficacy of sildenafil prescribed in primary care to erectile dysfunction patientsS Sunwoo, Y S Kim, B L Cho, et al.
Oncogene|September 26, 2017
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinomaM R Yun, H M Choi, H N Kang, et al.
International Journal of Impotence Research|October 17, 2003
Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean studyB L Cho, Y S Kim, Y S Choi, et al.
ESMO Open|September 15, 2022
The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus reportM C Hardenberg, B Patel, C Matthews, et al.
ESMO Open|October 26, 2024
Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinomaM H Hong, S Park, T Vo, et al.
ESMO Open|January 28, 2026
Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancerJ B Lee, K H Kim, S Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2019
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancerC G Kim, K H Kim, K-H Pyo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinomaH R Kim, H N Kang, H S Shim, et al.
ESMO Open|September 18, 2025
Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)S Hwang, M H Hong, S H Shin, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nanotechnology|August 12, 2011
Surface enhanced Raman scattering of silver sensitized cobalt nanoparticles in metal-dielectric nanocompositesJ Margueritat, J Gonzalo, C N Afonso, et al.
International Journal of Impotence Research|October 29, 2004
Post-marketing surveillance study of the safety and efficacy of sildenafil prescribed in primary care to erectile dysfunction patientsS Sunwoo, Y S Kim, B L Cho, et al.
Oncogene|September 26, 2017
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinomaM R Yun, H M Choi, H N Kang, et al.
International Journal of Impotence Research|October 17, 2003
Prevalence and risk factors for erectile dysfunction in primary care: results of a Korean studyB L Cho, Y S Kim, Y S Choi, et al.
ESMO Open|September 15, 2022
The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus reportM C Hardenberg, B Patel, C Matthews, et al.
ESMO Open|October 26, 2024
Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinomaM H Hong, S Park, T Vo, et al.
ESMO Open|January 28, 2026
Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancerJ B Lee, K H Kim, S Yoon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2019
Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancerC G Kim, K H Kim, K-H Pyo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinomaH R Kim, H N Kang, H S Shim, et al.
ESMO Open|September 18, 2025
Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)S Hwang, M H Hong, S H Shin, et al.
Pageof 7